UGI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Commercial Metals CMC Q1 2026 Earnings EPS Miss Overshadowed by Modest Share Gains VIVS Q3 2025 Earnings EPS Beat on Cost Management Amidst Ongoing Development C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution SCSC Q1 2026 Earnings EPS Slightly Misses Estimates Sentiment Remains Cautiously Optimistic MKTW Q1 2026 Earnings Staggering EPS Miss and Lack of Revenue Disclosure Raise Concerns